Drugs Made In America Acquisition Ownership | Who Owns Drugs Made In America Acquisition?


OverviewFinancialsChart

Drugs Made In America Acquisition Ownership Summary


Drugs Made In America Acquisition is owned by 114.92% institutional investors, 18.49% insiders. Karpus management is the largest institutional shareholder, holding 12.05% of DMAA shares. First Trust Merger Arbitrage Cl I is the top mutual fund, with 7.95% of its assets in Drugs Made In America Acquisition shares.

DMAA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDrugs Made In America Acquisition114.92%18.49%-33.41%
SectorFinancial Services Stocks 736.16%13.84%-650.00%
IndustryShell Companies Stocks 2343.89%14.43%-2258.32%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Karpus management2.53M12.05%$26.52M
First trust capital management2.24M10.67%$23.50M
Mizuho securities usa2.00M9.52%$20.90M
Glazer capital1.68M7.99%$17.59M
Westchester capital management1.67M7.94%$17.52M
Polar asset management partners1.60M7.62%$16.77M
Wolverine asset management1.55M7.40%$16.31M
Highbridge capital management1.32M6.30%$13.88M
Aristeia capital881.72K4.20%$9.24M
Heights capital management650.00K3.09%$6.83M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Atw spac management500.00K6.48%$5.13B
Heights capital management650.00K1.90%$6.83M
Rlh capital316.55K1.69%$3.32M
First trust capital management2.24M1.23%$23.50M
Karpus management2.53M0.83%$26.52M
Westchester capital management1.67M0.79%$17.52M
Quarry lp266.55K0.50%$2.80M
Mizuho securities usa2.00M0.49%$20.90M
Sandia investment management lp15.72K0.48%$161.46K
Highbridge capital management1.32M0.45%$13.88M

Top Buyers

HolderShares% AssetsChange
Highbridge capital management1.32M0.45%1.32M
Mizuho securities usa2.00M0.49%566.52K
Meteora capital380.30K0.29%380.30K
Rlh capital316.55K1.69%316.55K
Wolverine asset management1.55M0.16%246.24K

Top Sellers

HolderShares% AssetsChange
Mercuria capital strategies---750.00K
D. e. shaw---690.00K
Shaolin capital management---550.00K
Radcliffe capital management---546.81K
J. goldman & co lp---500.00K

New Positions

HolderShares% AssetsChangeValue
Highbridge capital management1.32M0.45%1.32M$13.88M
Meteora capital380.30K0.29%380.30K$3.99M
Rlh capital316.55K1.69%316.55K$3.32M
Sona asset management (us)162.79K0.04%162.79K$1.71M
Sandia investment management lp15.72K0.48%15.72K$161.46K

Sold Out

HolderChange
Citadel advisors-10.48K
Logan stone capital-10.90K
Bnp paribas arbitrage, snc-14.74K
Ubs group-38.16K
Virtu financial-46.69K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202639-24,142,4256.64%1141.19%13-13.33%7-
Dec 31, 202510-72.97%3,858,947-82.26%160.40%5-70.59%1-88.89%
Sep 30, 20258-75.00%3,373,368-83.80%100.26%5-72.22%1-83.33%
Jun 30, 20253233.33%20,823,19510.54%216,6200.00%18-21.74%6-
Mar 31, 202525-19,688,102-229,706-24---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
First Trust Merger Arbitrage Cl I1.93M7.95%-299.91K
Westchester Merger Arbitrage Composite1.63M6.70%-
The Merger Fund A1.63M6.70%-
Karpus Taxable Fixed Income454.58K1.87%-3.48K
Karpus Tax Sensitive Fixed Income434.73K1.79%38.00K
Karpus Conservative Balanced430.48K1.77%15.45K
RiverPark Short Term High Yield Instl264.87K1.09%264.87K
Karpus Growth Balanced252.50K1.04%12.28K
First Trust Multi-Strategy Cl I299.91K0.89%-
RiverNorth Opportunities100.00K0.41%-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 18, 2025Drugs Made In America Acquisition LLC-Buy-
Feb 18, 2025Drugs Made In America Acquisition LLC-Buy-
Feb 18, 2025Stockwell Lynn CEO and Exe. Chair of BoardBuy-
Feb 18, 2025Stockwell Lynn CEO and Exe. Chair of BoardBuy-
Jan 29, 2025Drugs Made In America Acquisition LLC-Buy-

Insider Transactions Trends


DateBuySell
2025 Q182

DMAA Ownership FAQ


Who Owns Drugs Made In America Acquisition?

Drugs Made In America Acquisition shareholders are primarily institutional investors at 114.92%, followed by 18.49% insiders and -33.41% retail investors. The average institutional ownership in Drugs Made In America Acquisition's industry, Shell Companies Stocks , is 2343.89%, which Drugs Made In America Acquisition falls below.

Who owns the most shares of Drugs Made In America Acquisition?

Drugs Made In America Acquisition’s largest shareholders are Karpus management (2.53M shares, 12.05%), First trust capital management (2.24M shares, 10.67%), and Mizuho securities usa (2M shares, 9.52%). Together, they hold 32.24% of Drugs Made In America Acquisition’s total shares outstanding.

Does Blackrock own Drugs Made In America Acquisition?

BlackRock is not among the top 10 institutional shareholders of Drugs Made In America Acquisition.

Who is Drugs Made In America Acquisition’s biggest shareholder by percentage of total assets invested?

Atw spac management is Drugs Made In America Acquisition’s biggest shareholder by percentage of total assets invested, with 6.48% of its assets in 500K Drugs Made In America Acquisition shares, valued at 5.14B$.

Who is the top mutual fund holder of Drugs Made In America Acquisition shares?

First Trust Merger Arbitrage Cl I is the top mutual fund holder of Drugs Made In America Acquisition shares, with 7.95% of its total shares outstanding invested in 1.93M Drugs Made In America Acquisition shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools